US Patent Issued to Inhibrx Biosciences on Jan. 13 for "CD28 single domain antibodies and multivalent and multispecific constructs thereof" (California Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,661, issued on Jan. 13, was assigned to Inhibrx Biosciences Inc. (La Jolla, Calif.).

"CD28 single domain antibodies and multivalent and multispecific constructs thereof" was invented by John C. Timmer (La Jolla, Calif.), Rutger H. Jackson (La Jolla, Calif.), Katelyn M. Willis (La Jolla, Calif.), William S. Crago (La Jolla, Calif.), Michael D. Kaplan (La Jolla, Calif.) and Brendan P. Eckelman (La Jolla, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are binding polypeptides that specifically bind CD28. More specifically, provided herein are fusion proteins, including multivalent and/or multispecific constructs that bind at leas...